Clinical Trial Update: Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial TRANSCAPE evaluating intestinal and multivisceral transplantation for unresectable mucinous carcinoma peritonei (pseudomyxoma peritonei);…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm of Peritoneum
• Malignant Neoplasm of Retroperitoneum
• Pseudomyxoma Peritonei

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Secondary Malignant Neoplasm of Retroperitoneum, Secondary Malignant Neoplasm of Peritoneum | Phase 2 | Status: NOT_YET_RECRUITING